Increasing pacemaker lead impedance and pacing threshold after initiation of chemotherapy with doxorubicin and cyclophosphamide

HeartRhythm Case Rep. 2022 Sep 24;8(12):845-848. doi: 10.1016/j.hrcr.2022.09.011. eCollection 2022 Dec.

Authors

Daniel L Varela¹, Karnika Ayinapudi¹, Bilal Ahmed¹, Christopher A Groh¹, Roger A Freedman¹

Affiliation

¹ Cardiology Division, University of Utah School of Medicine, Salt Lake City, Utah.

No abstract available

Keywords: Cardio-oncology; Cardiotoxicity; Chemotherapy; Cyclophosphamide; Doxorubicin; Pacemaker malfunction.

Publication types

Case Reports